Gerardo Morfini Selected Research

Microtubule-Associated Proteins (Microtubule-Associated Protein 2)

1/2019	Tau and Axonal Transport Misregulation in Tauopathies.
1/2017	Axonal Degeneration in Tauopathies: Disease Relevance and Underlying Mechanisms.
4/2012	Phosphorylation in the amino terminus of tau prevents inhibition of anterograde axonal transport.
11/2011	Heat shock protein 70 prevents both tau aggregation and the inhibitory effects of preexisting tau aggregates on fast axonal transport.
2/2009	The amino terminus of tau inhibits kinesin-dependent axonal transport: implications for filament toxicity.
1/2002	Fast axonal transport misregulation and Alzheimer's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gerardo Morfini Research Topics

Disease

8	Alzheimer Disease (Alzheimer's Disease) 10/2023 - 01/2002
6	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 01/2002
5	Tauopathies 01/2017 - 02/2009
3	Hereditary Spastic Paraplegia 08/2021 - 02/2008
2	Cognitive Dysfunction 01/2016 - 11/2011
2	Neoplasms (Cancer) 07/2013 - 09/2011
1	Multiple Sclerosis 01/2023
1	Virus Diseases (Viral Diseases) 01/2021
1	Pathologic Processes 01/2019
1	Polyneuropathies (Polyneuropathy) 01/2015
1	Peripheral Nervous System Diseases (PNS Diseases) 07/2013
1	Demyelinating Diseases (Demyelinating Disease) 06/2013
1	Globoid Cell Leukodystrophy (Krabbe Disease) 06/2013
1	Astrocytoma (Pilocytic Astrocytoma) 09/2011
1	Glioblastoma (Glioblastoma Multiforme) 09/2011
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 11/2010
1	Parkinson Disease (Parkinson's Disease) 02/2007
1	X-Linked Bulbo-Spinal Atrophy 07/2006
1	Frontotemporal Dementia (Semantic Dementia) 01/2002
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2002

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 10/2023 - 07/2006
6	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2019 - 01/2002
4	SpastinIBA 08/2021 - 02/2008
2	Amyloid (Amyloid Fibrils)IBA 10/2023 - 11/2013
2	EnzymesIBA 08/2021 - 09/2011
2	Phosphotransferases (Kinase)IBA 01/2021 - 01/2017
2	tau Proteins (tau Protein)IBA 11/2016 - 01/2016
2	KinesinsIBA 01/2016 - 06/2013
2	Peptides (Polypeptides)IBA 11/2013 - 11/2009
2	polyglutamineIBA 07/2006 - 02/2005
1	JNK Mitogen-Activated Protein KinasesIBA 01/2023
1	Protein Isoforms (Isoforms)IBA 11/2016
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2016
1	Glycoproteins (Glycoprotein)IBA 01/2015
1	ixabepilone (BMS 247550)FDA Link 07/2013
1	eribulin FDA Link 07/2013
1	Paclitaxel (Taxol)FDA LinkGeneric 07/2013
1	Vincristine (Oncovin)FDA LinkGeneric 07/2013
1	GalactosylceramidaseIBA 06/2013
1	Psychosine (Galactosylsphingosine)IBA 06/2013
1	SphingolipidsIBA 06/2013
1	Adenosine Triphosphatases (ATPase)IBA 09/2011
1	CopperIBA 11/2010
1	ZincIBA 11/2010
1	Superoxide Dismutase-1IBA 11/2010
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 11/2009
1	Amyloid beta-PeptidesIBA 11/2009
1	1-Methyl-4-phenylpyridinium (1 Methyl 4 phenylpyridinium)IBA 02/2007
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 02/2007
1	Androgen Receptors (Androgen Receptor)IBA 07/2006

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 07/2013